Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2016-02-29 Share Issue/Capital Cha…
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
2016.02.29 PR GENFIT Private Placement
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" and announces that GENFIT has raised EUR 49.6 million through a private placement of new shares. This action directly relates to fundraising, financing activities, and changes in capital structure (issuance of new shares). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it involves shares, it is a financing event announcement, not a general share repurchase (POS) or a general capital change announcement (SHA), but specifically a capital raise via placement. It is not a full report (10-K, IR) or a simple announcement of a report (RPA).
2016-02-29 English
2016.02.29 CP GENFIT Placement Privé
Share Issue/Capital Change Classification · 99% confidence The document is a press release ('COMMUNIQUÉ DE PRESSE') announcing that GENFIT has raised 49.6 million Euros through a private placement ('placement privé') involving the issuance of new shares. This action directly relates to the company's fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it mentions the Annual Financial Report ('Rapport Financier Annuel'), the primary purpose of this specific document is the capital raise announcement, not the report itself. Therefore, CAP is the most appropriate classification.
2016-02-29 French
2016.02.15 CP GENFIT Mise à disposition RAF 2015
Report Publication Announcement Classification · 100% confidence The document is a press release announcing the availability and filing of the company's 2015 Annual Financial Report. It does not contain the actual financial statements themselves, but rather provides a link to where they can be accessed. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA). FY 2015
2016-02-15 French
2016.02.15 PR GENFIT Annual financial report 2015 available
Report Publication Announcement Classification · 98% confidence The document is a short press release titled "GENFIT: 2015 ANNUAL FINANCIAL REPORT AVAILABLE". It explicitly states that the '2015 annual financial report is publicly available and filed with the French Financial Markets Authority (AMF)' and provides a direct link to the PDF of that report. According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of a full report (like an Annual Financial Report), it should be classified as a Report Publication Announcement (RPA), not the report itself (which would typically be a 10-K or AR if it were the full document). Since this is an announcement of the availability of the 2015 Annual Financial Report, RPA is the most appropriate classification.
2016-02-15 English
GENFIT: 2015 Annual Financial and Management Report
Annual Report Classification · 100% confidence The document is titled 'ANNUAL FINANCIAL REPORT 2015' and contains comprehensive financial statements, management reports, and auditor reports for the fiscal year ending December 31, 2015. It is a full-length annual report, not an announcement or a summary, and therefore fits the definition of a 10-K (Annual Report). FY 2015
2016-02-15 English
2016.02.11 PR GENFIT GOLDEN-505 Results Publication Gastroenterolog
Regulatory Filings Classification · 95% confidence The document is a press release dated February 11, 2016, announcing that detailed results from a Phase 2b clinical trial (GOLDEN-505) for the drug Elafibranor have been published online in the peer-reviewed journal *Gastroenterology*. It summarizes key findings, includes quotes from investigators and the CSO, and provides boilerplate information about the drug, NASH, and the company (GENFIT). This is not a formal regulatory filing like a 10-K or an IR, nor is it a transcript (CT) or a formal earnings release (ER). It is an announcement regarding scientific/clinical data dissemination. Since it is a press release announcing the publication of scientific data and clinical trial results, it best fits the category of a general announcement or regulatory filing that doesn't fit elsewhere, or potentially an Investor Presentation (IP) if it were structured as a deck, but given the format and content focus on a specific scientific publication milestone, the most appropriate general category is Regulatory Filings (RNS) as a catch-all for significant, non-standard corporate announcements, or potentially an Investor Presentation (IP) if the intent is to inform investors of a major development. Given the focus on the publication itself rather than a strategic investor overview, RNS is a safer fit, though it shares characteristics with IP. However, since it is a press release announcing a scientific publication milestone, and not a formal report itself, RNS (Regulatory Filings/General Announcement) is the best fit among the provided options for this type of corporate communication.
2016-02-11 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.